Profound Medical (PROF) Competitors

Profound Medical (NASDAQ:PROF) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk, community ranking and dividends.

Does the media prefer PROF or BFLY?

In the previous week, Profound Medical had 5 more articles in the media than Butterfly Network. MarketBeat recorded 6 mentions for Profound Medical and 1 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 1.67 beat Profound Medical's score of 0.45 indicating that Butterfly Network is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Butterfly Network	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Is PROF or BFLY more profitable?

Butterfly Network has a net margin of -129.25% compared to Profound Medical's net margin of -349.41%. Butterfly Network's return on equity of -42.68% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-349.41%	-85.22%	-64.87%
Butterfly Network	-129.25%	-42.68%	-30.31%

Which has preferable earnings and valuation, PROF or BFLY?

Profound Medical has higher earnings, but lower revenue than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$11.86M	12.98	-$28.57M	-$1.22	-4.20
Butterfly Network	$85.63M	6.40	-$133.70M	-$0.29	-7.64

Does the MarketBeat Community prefer PROF or BFLY?

Profound Medical received 33 more outperform votes than Butterfly Network when rated by MarketBeat users. However, 72.73% of users gave Butterfly Network an outperform vote while only 71.93% of users gave Profound Medical an outperform vote.

Company	Underperform	Outperform
Profound Medical	Outperform Votes 41 71.93%	Underperform Votes 16 28.07%
Butterfly Network	Outperform Votes 8 72.73%	Underperform Votes 3 27.27%

Do analysts rate PROF or BFLY?

Profound Medical presently has a consensus target price of $11.50, indicating a potential upside of 124.43%. Butterfly Network has a consensus target price of $4.00, indicating a potential upside of 80.59%. Given Profound Medical's higher probable upside, research analysts plainly believe Profound Medical is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Butterfly Network	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk & volatility, PROF or BFLY?

Profound Medical has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.59, meaning that its stock price is 159% more volatile than the S&P 500.

Do institutionals & insiders believe in PROF or BFLY?

47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 37.8% of Butterfly Network shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by insiders. Comparatively, 25.2% of Butterfly Network shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Butterfly Network beats Profound Medical on 9 of the 16 factors compared between the two stocks.